Home › Funds › Geode Capital Management › ABUS
Geode Capital Management position in ABUS
ARBUTUS BIOPHARMA CORP · Health Care
Latest position (Q2 2026)4.12M sh
Reported value held$19.77M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.54M | $6.61M | New |
| Q4 2021 | 1.67M | $6.49M | Add |
| Q1 2022 | 1.73M | $5.16M | Add |
| Q2 2022 | 1.79M | $4.84M | Add |
| Q3 2022 | 2.01M | $3.84M | Add |
| Q4 2022 | 2.13M | $4.96K | Add |
| Q1 2023 | 2.29M | $6.93M | Add |
| Q2 2023 | 2.60M | $5.98M | Add |
| Q3 2023 | 2.70M | $5.48M | Add |
| Q4 2023 | 2.82M | $7.04M | Add |
| Q1 2024 | 2.96M | $7.63M | Add |
| Q2 2024 | 3.31M | $10.24M | Add |
| Q3 2024 | 3.45M | $13.28M | Add |
| Q4 2024 | 3.48M | $11.39M | Add |
| Q1 2025 | 3.54M | $12.36M | Add |
| Q2 2025 | 3.64M | $11.24M | Add |
| Q3 2025 | 3.67M | $16.65M | Add |
| Q4 2025 | 3.68M | $17.69M | Hold |
| Q1 2026 | 3.77M | $16.98M | Add |
| Q2 2026 | 4.12M | $19.77M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABUS
- Morgan Stanley 17.70M sh · $84.95M · Q2 2026
- BlackRock Inc 13.77M sh · $66.08M · Q2 2026
- Vanguard Group 9.24M sh · $44.46M · Q4 2025
- Goldman Sachs Group 3.51M sh · $16.83M · Q2 2026
- Bank of America Corp 2.65M sh · $12.70M · Q2 2026
- Legal & General Investment Management America 2.47M sh · $11.84M · Q2 2026
- Charles Schwab Investment Management 1.43M sh · $6.87M · Q2 2026
- Northern Trust Corp 1.42M sh · $6.81M · Q2 2026
- Citigroup Inc 879.24K sh · $4.22M · Q2 2026
- Arrowstreet Capital 650.70K sh · $3.12M · Q2 2026
- Wellington Management Group 461.65K sh · $2.22M · Q2 2026